Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OmniAb, Inc. - Common Stock (NQ: OABI )

5.010 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.010
Bid (Size) 0.7538 (5)
Ask (Size) 17.34 (14)
Prev. Close 5.010
Today's Range 5.010 - 5.010
52wk Range 1.910 - 5.975
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OmniAb to Participate in Two Investor Conferences in September
From OmniAb, Inc.
Via Business Wire
OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire

Performance

YTD
+44.38%
+44.38%
1 Month
-10.85%
-10.85%
3 Month
+3.30%
+3.30%
6 Month
+56.07%
+56.07%
1 Year
+107.88%
+107.88%

More News

Read More
OmniAb Announces the Passing of Director Sunil Patel
From OmniAb, Inc.
Via Business Wire
OmniAb to Report Second Quarter 2023 Financial Results on August 10
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For August 10, 2023
Via Benzinga
7 Stocks to Buy for 200% Returns This Year
Via InvestorPlace
7 Stocks to Buy for Their Massive Upside Potential
Via InvestorPlace
OmniAb Launches OmniDeep™ at the PEGS Boston Conference and Expo
From OmniAb, Inc.
Via Business Wire
Stratasys, Navitas Semiconductor, United Insurance And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
$1.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
OmniAb Reports First Quarter 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb to Report First Quarter 2023 Financial Results on May 11
From OmniAb, Inc.
Via Business Wire
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
Via InvestorPlace
OmniAb to Participate in Upcoming Investor Conferences in May
From OmniAb, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
Via Benzinga
OmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For March 30, 2023
Via Benzinga
7 Biotech Stocks That Could Be the Next Big Thing
Via InvestorPlace
OmniAb to Report Fourth Quarter 2022 Financial Results on March 30
From OmniAb, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
Via Benzinga
OmniAb to Participate in Three Upcoming Investor Conferences
From OmniAb, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
Via Benzinga
Some 'Transgenic Animal Platforms Are More Than Equal,' Analyst Initiating Coverage On OmniAb Says
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.